Cross Country Healthcare Inc (CCRN)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Cross Country Healthcare Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
52-Week Range
Current price 13.30 $ — 87% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/04/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AAQS
1/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 2.6%
- Exp. sales growth 3Y > 5% -1.2%
- EBIT growth 10Y > 5% –
- Exp. EBIT growth 3Y > 5% -1.2%
- Net debt < 4x EBIT –
- EBIT positive, 10Y straight 5
- Max. EBIT decline < 50% 100.0%
- Return on equity > 15% -41.0%
- ROCE > 15% -0.9%
- Expected return > 10% 7.9%
View all AAQS quality stocks · Read the methodology at AlleAktien
Source: fundamental data
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
3 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -27.8% failed
- More than 10% revenue growth is expected for the coming year 4.1% failed
- Share count grows by less than 3% a year -4.8% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -17.8% failed
- Gross margin at 40% or higher and without meaningful erosion 18.7% failed
- Goodwill from acquisitions does not grow faster than revenue 14.2% failed
- Net debt below twice EBITDA 106 m net cash passed
- Operating cash flow covers the profits of the last three years 454 m passed
- Return on capital at 15% or higher, or up versus two years ago -0.9% failed
- Insiders hold at least 10% or are net buyers 7.5% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 6.5% below the current price.
- Consensus
- Hold
- Analyst Ratings
- 7
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 0.11 | 0.09 – 0.15 | 989 | 470.0% | 5 |
| 12/31/2027 | 0.29 | 0.24 – 0.35 | 1,028 | 155.9% | 6 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.03 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.12 | -144.50 | 310 | -25.10 | -1.20 | 24 | 22 |
| 2025: Q1 | -0.02 | -119.50 | 293 | -22.60 | -0.20 | 6 | 4 |
| 2025: Q2 | -0.20 | – | 274 | -19.30 | -2.40 | 4 | 2 |
| 2025: Q3 | -0.15 | -289.90 | 250 | -20.60 | -1.90 | 20 | 18 |
| 2025: Q4 | -2.56 | – | 237 | -23.60 | -35.00 | 18 | 16 |
| 2026: Q1 | -0.14 | – | 241 | -17.80 | -1.80 | 5 | 3 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 834 | 6 | 8 | 0.22 | 30 | 151 | 388 |
| 2017 | 865 | 12 | 38 | 1.04 | 46 | 237 | 468 |
| 2018 | 816 | -13 | -17 | -0.48 | 21 | 218 | 427 |
| 2019 | 822 | -16 | -58 | -1.61 | 6 | 163 | 382 |
| 2020 | 836 | -9 | -13 | -0.36 | 27 | 154 | 357 |
| 2021 | 1,677 | 139 | 132 | 3.53 | -86 | 298 | 733 |
| 2022 | 2,803 | 270 | 186 | 4.95 | 134 | 457 | 948 |
| 2023 | 2,020 | 113 | 73 | 2.05 | 249 | 473 | 679 |
| 2024 | 1,344 | -17 | -15 | -0.44 | 120 | 419 | 589 |
| 2025 | 1,054 | -3 | -95 | -2.93 | 48 | 323 | 449 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Cross Country Healthcare, Inc. bietet Talentmanagement-Dienstleistungen für Kunden im Gesundheitswesen in den USA an.
| Employees | 7,890 |
|---|---|
| Headquarters | Boca Raton, FL |
| Address | 5201 Congress Avenue, 33487 Boca Raton, United States |
| Phone | 561 998 2232 |
| Website | crosscountry.com |
| IPO Date | 25. Oct 2001 |
| ISIN | US2274831047 |
Management
| Name | Title | Birth Year |
|---|---|---|
| William J. Burns CPA, M.B.A. | Executive VP & CFO | 1970 |
| Susan E. Ball J.D., M.B.A., R.N. | Chief Administrative Officer, Executive VP, General Counsel & Secretary | 1964 |
| Marc S. Krug J.D., M.B.A. | Group President of Delivery, CCN, CCA & CCE | 1968 |
| Amiee Hawkins | Chief Operating Officer | 1980 |
| Marvin Veizaga CPA | Senior VP & Chief Accounting Officer | 1981 |
| Chris Tyrell | Chief Information Officer | – |
| Joshua David Vogel | Vice President of Investor Relations | – |
| Karen Varga-Sinka | Director of Corporate Communications | – |
| Gerald Purgay | Chief Marketing Officer | 1961 |
| Mark Fortunato | Vice President of Corporate Development | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 21. Jul 2026 | Veizaga Marvin | Chief Accounting Officer | Other | 16,797 | 13.25 | 222,560 |
| 21. Jul 2026 | Veizaga Marvin | Chief Accounting Officer | Other | 16,797 | 0.00 | – |
| 21. Jul 2026 | Veizaga Marvin | Chief Accounting Officer | Other | 31,480 | 13.25 | 417,110 |
| 21. Jul 2026 | Hawkins Amiee Lin | Chief Operating Officer | Other | 27,897 | 13.25 | 369,635 |
| 21. Jul 2026 | Hawkins Amiee Lin | Chief Operating Officer | Other | 27,897 | 0.00 | – |
| 21. Jul 2026 | Hawkins Amiee Lin | Chief Operating Officer | Other | 43,953 | 13.25 | 582,377 |
| 21. Jul 2026 | Krug Marc S. | Group President, Delivery | Other | 47,120 | 13.25 | 624,340 |
| 21. Jul 2026 | Krug Marc S. | Group President, Delivery | Other | 47,120 | 0.00 | – |
| 21. Jul 2026 | Krug Marc S. | Group President, Delivery | Other | 77,232 | 13.25 | 1,023,324 |
| 21. Jul 2026 | Ball Susan E | General Counsel and Secretary | Other | 72,872 | 13.25 | 965,554 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.